ÂÜÀòÂÒÂ×

Ed Sopp has extensive experience in quality assurance in the pharmaceutical industry. Ed started their career in 1989 at Damon Biotech in a production role. Ed then worked as a QC employee at Abbott Biotech and Repligen Corporation before joining GelTex Pharmaceuticals as a QC/QA employee in 1995. In 2003, they became a QA Associate Director at Genzyme, followed by QA Director roles at Nitromed, Proteon Therapeutics, and Concert Pharmaceuticals. From 2015 to 2018, they served as the Senior Director of Quality Assurance at Kala Pharmaceuticals. Currently, they are the Vice President/Head of Quality Assurance at Spero Therapeutics, overseeing all drug development candidates' quality assurance and compliance with regulatory guidelines.

Ed Sopp attended Bridgewater State University from 1985 to 1989, where they earned a Bachelor of Science degree. Ed also attended St. Johns Prep, although the specific dates are unknown.